COMMUNIQUÉS West-GlobeNewswire

Intermountain Healthcare’s Leadership Institute Inaugural Class Begins in October

02/07/2018 - 17:25

Esteemed faculty is comprised of accomplished experts in healthcare, leadership, business, and academia. Salt Lake City, Utah, July 02, 2018 (GLOBE NEWSWIRE) -- Led by President and CEO Emeritus Charles W. Sorenson, MD [...]

Elsalys Biotech : New studies confirm anti-CD160 potential in ophthalmology

02/07/2018 - 17:01

New studies confirm anti-CD160 antibodies are potential therapeutics for ophthalmic diseases Efficacy and safety are consistently demonstrated in several in vivo preclinical models Anti-CD160 is a potent inhibitor of [...]

Publication of overall statement from the board of directors in respect of (a) the takeover offer made by Gefion Group Investments A/S and (b) the takeover offer made by Nordic Transport Group Holding A/S

02/07/2018 - 16:16

Company Announcement 2 July 2018 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH [...]

Oryzon to present at upcoming international conferences

02/07/2018 - 15:45

European Biotech Investor Day in NYC, New York, USA The Alzheimer's Association International Conference AAIC- 2018 – Chicago, USA MADRID, Spain and CAMBRIDGE, Mass., July 02, 2018 (GLOBE NEWSWIRE) -- Oryzon Genomics ( [...]

Greystone Skilled Nursing Centers Earn National AHCA Quality Awards

02/07/2018 - 15:32

TAMPA, Fla., July 02, 2018 (GLOBE NEWSWIRE) -- Seven Greystone health and rehabilitation centers located throughout Florida are recipients of National Quality Awards by the American Health Care Association (AHCA) for [...]

NYMOX Announces Expanded Marketing Plans

02/07/2018 - 15:30

HASBROUCK HEIGHTS, N.J., July 02, 2018 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) announced today that following the recently announced increased manufacturing capabilities, the Company has [...]

Mandatory notification of trade

02/07/2018 - 15:18

Reference is made to the announcement today from Vistin Pharma ASA ("Vistin Pharma") regarding employee share options. Torbjørn Kjus, Asset Manager, has been granted 2,400,000 share options at an exercise price of NOK [...]

Progressive Care Completes Acquisition of Touchpoint Pharmacy Expanding Company Footprint and Market Opportunity

02/07/2018 - 15:18

MIAMI, July 02, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a personalized healthcare services and technology company, today announced that it has completed the acquisition of a Touchpoint pharmacy in [...]

Vistin Pharma ASA : Employee share options

02/07/2018 - 15:10

Oslo, 2 July 2018 Reference is made to the Company's announcements on 16 March and 22 March regarding the establishment of a new business area and the completion of a private placement. In connection with the [...]

Sienna Biopharmaceuticals Enters $40 Million Term Loan Agreement

02/07/2018 - 15:05

WESTLAKE VILLAGE, Calif., July 02, 2018 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA) today announced that the Company has entered a $40 million term loan agreement with Silicon Valley Bank. Sienna [...]

TESARO Partners With the Pan-Mass Challenge for 2018 Ride Benefiting Dana-Farber Cancer Institute

02/07/2018 - 15:00

WALTHAM, Mass., July 02, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, is proud to announce a new partnership supporting the Pan-Mass Challenge (PMC). The PMC is the [...]

Fibrocell Announces $4.0 Million Registered Direct Offering Priced At-the-Market

02/07/2018 - 15:00

EXTON, Pa., July 02, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ:FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today [...]

MPI - Strong LiPlaCis Treatment Results in DRP-Selected Breast Cancer Patients - Collaborative LiPlaCis Regulatory Meeting with DKMA

02/07/2018 - 14:31

Oncology Venture Provides Clinical and Business Update Hoersholm, Denmark, July 2, 2018 -Medical Prognosis Institute (Nasdaq First North; MPI:ST) and Oncology Venture Sweden AB (SPOTLIGTH: OV.ST) ("OV" or "the Company [...]

Fortress Biotech Announces Cyprium Therapeutics’ CUTX-101 (Copper Histidinate) Granted FDA Fast Track Designation for Treatment of Classic Menkes Disease

02/07/2018 - 14:30

NEW YORK, July 02, 2018 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ:FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology [...]

Yield10 Bioscience Begins Field Testing of Novel Yield Trait Gene C3003 and Novel Trait Gene C3008 in Oilseed Crops

02/07/2018 - 14:30

WOBURN, Mass., July 02, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN), a Company developing new technologies to create step-change improvements in crop yield to enhance global food security, announced [...]

Shire plc : Total voting rights

02/07/2018 - 14:01

Total Voting Rights July 2, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company"), in accordance with 5.6.1R of the Financial Conduct Authority's (the "FCA") Disclosure Guidance and Transparency Rules, notifies the [...]

Amedisys Announces New $550 Million Senior Secured Credit Facility

02/07/2018 - 14:00

BATON ROUGE, La., July 02, 2018 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ:AMED), America's leading independent home health, hospice care and personal care company, announced today that it entered into a new secured [...]

George Bikhazi, MD is Elected to the American Health Council’s Physician Board

02/07/2018 - 14:00

NEW YORK, July 02, 2018 (GLOBE NEWSWIRE) -- The American Health Council recently elected George Bikhazi, MD to its Physician Board for his outstanding career in the medical field. Although Dr. Bikhazi retired as a [...]

Zogenix Welcomes New Global Chief Commercial Officer

02/07/2018 - 14:00

Ashish Sagrolikar Brings Over 25 Years of Global Pharmaceutical Sales, Marketing and Operations Experience to Zogenix EMERYVILLE, Calif., July 02, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical [...]